BERNY J. KREUTZ, MD

BETHESDA, MD

Research Active
Surgery NPI registered 21+ years 13 publications 1984 – 2022 NPI: 1629073549
MiceAmino Acid SequenceHEK293 CellsSignal TransductionProtein BindingGuanine Nucleotide Exchange FactorsCell MovementHeLa CellsCell AdhesionProtein Structure, TertiaryRGS ProteinsGTP-Binding Protein alpha Subunits, G12-G13Rho Guanine Nucleotide Exchange FactorsrhoA GTP-Binding ProteinProtein Interaction Domains and Motifs

Practice Location

6420 ROCKLEDGE DR
BETHESDA, MD 20817-7837

Phone: (301) 896-6880

What does BERNY KREUTZ research?

Dr. Kreutz studies how different proteins and signaling pathways work within our cells, particularly focusing on those that affect inflammation, blood pressure, and cell movement. He has developed advanced methods for measuring inflammation accurately, which is crucial in managing diseases that involve inflammatory processes. His research has implications for patients suffering from conditions such as cancer, hypertension, and other diseases related to cell behavior, making his findings relevant for improved therapies and patient outcomes.

Key findings

  • Developed an automated IL-6 immunoassay that is 10 times more sensitive than prior methods, detecting inflammation at levels as low as 0.317 picograms per milliliter.
  • Discovered that altering Gα13 protein interactions can reduce cell migration by affecting RhoA signaling, important for treating cancer and aiding wound recovery.
  • Identified a specific interaction between RGS2 and Gαq that helps regulate blood pressure, potentially leading to new treatments for hypertension.
  • Demonstrated that proteasome inhibitors can reduce smooth muscle alpha-actin levels under certain conditions, pointing to new ways to control muscle cell behavior in blood vessels.

Frequently asked questions

Does Dr. Kreutz study inflammation?
Yes, he has developed a highly sensitive test for measuring IL-6, a protein associated with inflammation, which can help in managing inflammatory diseases.
What conditions are linked to Dr. Kreutz's research?
His research is relevant for patients with inflammatory diseases, cancer, and hypertension, as he studies the underlying cellular mechanisms that affect these conditions.
What treatments has Dr. Kreutz researched?
He has researched potential treatments related to blood pressure regulation, inflammation management, and cancer therapies by understanding key cellular interactions.
Is Dr. Kreutz's work relevant to cancer patients?
Yes, his research on cell migration and signaling pathways offers insights that could improve treatment strategies for cancer patients.
How does Dr. Kreutz's research impact blood pressure management?
His findings on the interaction between RGS2 and Gαq provide potential pathways for developing new therapies aimed at controlling high blood pressure.

Publications in plain English

Development of a new automated IL-6 immunoassay.

2022

Journal of immunological methods

Israeli E, Okura H, Kreutz B, Piktel R, Hadji A +9 more

Plain English
Researchers developed a new automated test for measuring IL-6, a protein that indicates inflammation in the body. This test is 10 times more sensitive than an existing method, detecting IL-6 levels as low as 0.317 picograms per milliliter, which means it can identify inflammation more accurately. This improved test can help doctors monitor and manage inflammatory conditions more effectively, leading to better patient care. Who this helps: Patients with inflammatory diseases.

PubMed

The interaction of Gα13 with integrin β1 mediates cell migration by dynamic regulation of RhoA.

2015

Molecular biology of the cell

Shen B, Estevez B, Xu Z, Kreutz B, Karginov A +5 more

Plain English
This study looked at how a protein called Gα13 interacts with another protein, integrin β1, to help cells move. The researchers found that when they changed certain parts of the proteins (like using a specific mutation), it stopped Gα13 from working with integrin β1, which led to reduced cell movement. This is important because understanding how cell migration is regulated can help in developing treatments for conditions where this process is disrupted, such as in cancer or wound healing. Who this helps: Patients with cancer or those recovering from injuries.

PubMed

Structural and functional analysis of the regulator of G protein signaling 2-gαq complex.

2013

Structure (London, England : 1993)

Nance MR, Kreutz B, Tesmer VM, Sterne-Marr R, Kozasa T +1 more

Plain English
This study investigated how a protein called RGS2 interacts with another protein, Gαq, which is important in regulating blood pressure. Researchers discovered that RGS2 binds to Gαq in a unique way that enhances its ability to control blood pressure by inhibiting excessive signaling; specifically, they found RGS2 has strong interactions that boost its effectiveness as an inhibitor. These findings are important because understanding this interaction could lead to new treatments for high blood pressure. Who this helps: This helps patients with hypertension.

PubMed

Different Raf protein kinases mediate different signaling pathways to stimulate E3 ligase RFFL gene expression in cell migration regulation.

2013

The Journal of biological chemistry

Gan X, Wang C, Patel M, Kreutz B, Zhou M +2 more

Plain English
This study looked at how specific proteins, called Ras proteins, affect the movement of cells by influencing the expression of a gene that helps regulate cell migration. The researchers found that a protein named Gα12 interacts specifically with another protein, ARAF, activating it and leading to increased expression of the gene RFFL. They discovered that this pathway is important for cell migration, and that other growth signals can also enhance cell movement through a similar mechanism. Who this helps: This helps researchers and doctors understand how cell movement is controlled, which can be important for treatments related to cancer and wound healing.

PubMed

VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions.

2012

Molecular cell

Komarova YA, Huang F, Geyer M, Daneshjou N, Garcia A +4 more

Plain English
This study looked at how a protein called VE-cadherin helps control the barrier function of blood vessels by regulating cell connections. Researchers found that when VE-cadherin function is lost, it triggers a series of reactions that lead to changes in another protein, EB3, which then affects how cells connect to each other. Specifically, they discovered that the activity of EB3 can either support or break down these connections, which is crucial for maintaining the integrity of blood vessel walls. Who this helps: This research benefits doctors and researchers studying blood vessel health and diseases related to endothelial barriers.

PubMed

Structure and function of the interacting domains of Spire and Fmn-family formins.

2011

Proceedings of the National Academy of Sciences of the United States of America

Vizcarra CL, Kreutz B, Rodal AA, Toms AV, Lu J +3 more

Plain English
This study looked at two important proteins, Spire and Cappuccino, which work together to help build a structure made of a substance called actin during the development of fruit fly eggs. The researchers found that a specific part of Spire interacts with the tail of Cappuccino, which is essential for this process. They discovered that this interaction actually prevents Cappuccino from starting new actin structures while helping it to be removed from the ends of existing ones, showing how these proteins cooperate in the assembly of actin. Who this helps: This research benefits scientists studying cell development and could lead to advancements in understanding certain diseases related to cell movement.

PubMed

Distinct regions of Galpha13 participate in its regulatory interactions with RGS homology domain-containing RhoGEFs.

2007

Cellular signalling

Kreutz B, Hajicek N, Yau DM, Nakamura S, Kozasa T

Plain English
This study looked at how a protein called Galpha13 interacts with other proteins to activate a signaling pathway important for cell regulation. Researchers found that a specific part of Galpha13 is necessary for stimulating the activity of proteins that help trigger the RhoA signaling pathway, while different regions are responsible for how quickly Galpha13 can respond in this process. This research is important because understanding these interactions can lead to better insights into cellular communication and may help develop new treatments for diseases related to cell signaling. Who this helps: Patients with conditions linked to cell signaling disorders.

PubMed

A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12/13) proteins.

2006

Biochemistry

Kreutz B, Yau DM, Nance MR, Tanabe S, Tesmer JJ +1 more

Plain English
This study focused on improving the production of certain G proteins called G alpha(12/13), which play a role in important cell functions like growth and movement. Researchers created modified versions of these proteins that were easier to study and found that they acted similarly to their natural forms, revealing key details about how they work. They discovered new structural changes in these proteins that help explain how they perform their functions in the body. Who this helps: This benefits researchers and scientists working on cell biology and cancer treatment.

PubMed

Regulation of serum response factor-dependent gene expression by proteasome inhibitors.

2005

Molecular pharmacology

Sandbo N, Qin Y, Taurin S, Hogarth DK, Kreutz B +1 more

Plain English
This study looked at how certain drugs that inhibit protein breakdown affect the expression of a key protein related to muscle cells in blood vessels. Researchers found that using these drugs actually reduced the levels of smooth muscle alpha-actin (SMA) in response to a growth factor called endothelin-1 (ET1), rather than increasing them. Specifically, when they used drugs like MG132 and lactacystin, SMA production decreased despite the cells remaining alive, indicating that these drugs inhibit the activity of a factor called serum response factor (SRF) that drives SMA expression. Who this helps: This research benefits doctors and scientists trying to understand how blood vessel muscle cell behavior can be controlled in diseases like high blood pressure.

PubMed

Critical role of lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and leukemia-associated RhoGEF.

2004

Molecular pharmacology

Nakamura S, Kreutz B, Tanabe S, Suzuki N, Kozasa T

Plain English
This study focused on a specific part of a protein called Galpha13 and how it helps regulate two other proteins involved in cell signaling, p115 and LARG. Researchers discovered that altering a particular part of Galpha13, known as lysine 204, reduced its ability to activate p115 and LARG by about 70% in certain cell experiments. Understanding this interaction is important because it sheds light on how cellular signals are regulated, which could impact the treatment of diseases like cancer. Who this helps: This information helps researchers and doctors working on cancer treatments.

PubMed

Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins.

2004

Methods in enzymology

Tanabe S, Kreutz B, Suzuki N, Kozasa T

Plain English
This study looked at three specific proteins, known as Rho guanine nucleotide exchange factors (or RhoGEFs), which are important for sending signals inside cells. The researchers found that these proteins are controlled by two other proteins called Galpha12 and Galpha13. Specifically, they measured how well RhoGEFs activate Rho GTPases, which is essential for various cellular functions like changing cell shape or turning on genes; their findings revealed they can effectively gauge this activity using specific binding measurements. Who this helps: This helps researchers and scientists studying cell signaling and its implications in diseases.

PubMed

RGS16 inhibits signalling through the G alpha 13-Rho axis.

2003

Nature cell biology

Johnson EN, Seasholtz TM, Waheed AA, Kreutz B, Suzuki N +4 more

Plain English
This research studied how a protein called RGS16 interacts with a signaling pathway that involves G alpha 13 and RhoA, which are important for various cell functions. The study found that RGS16 directly binds to G alpha 13, preventing it from activating RhoA and changing cell behavior. Specifically, RGS16 can inhibit processes that would normally lead to changes in cell shape and gene activity, providing insights into how this regulation works. Who this helps: This helps researchers and doctors who are looking to understand cell signaling in diseases.

PubMed

Construction of Staphylococcus plasmid vector pCA43 conferring resistance to chloramphenicol, arsenate, arsenite and antimony.

1984

Gene

Kreutz B, Götz F

Plain English
This study focused on creating a new plasmid, called pCA43, which helps bacteria resist certain harmful substances, including chloramphenicol and different types of arsenic. They successfully engineered this plasmid to not only provide resistance to these toxins but also maintained its stability during tests. This research is important because it could lead to better understanding of how bacteria adapt to toxic environments, which is crucial for fighting antibiotic resistance. Who this helps: This benefits doctors and researchers working to combat bacterial infections.

PubMed

Frequent Co-Authors

Tohru Kozasa Shihori Tanabe Nobuchika Suzuki Mark R Nance John J G Tesmer Douglas M Yau Susumu Nakamura Eitan Israeli Hideaki Okura Ryan Piktel

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.